EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026)

EyePoint (EYPT) reported Change in Acquisitions & Divestments of $70.0 million for Q1 2026, down 11.64% on a YoY basis from $79.2 million in Q1 2025, and down 6.67% sequentially from $75.0 million in Q4 2025.

EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $70.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 11.64% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $314.5 million (up 30.92% YoY), and the FY2025 full-year result was $323.7 million, up 76.9% from the prior year.
  • Change in Acquisitions & Divestments eased to $70.0 million in Q1 2026, from $75.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $103.5 million in Q2 2025 to a low of $3.0 million in Q4 2023.
  • A 5-year average of $47.3 million and a median of $44.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments slumped 93.62% in 2023 and surged 2183.33% in 2024, its largest moves.
  • Tracing EYPT's Change in Acquisitions & Divestments over 5 years: stood at $47.0 million in 2022, then tumbled by 93.62% to $3.0 million in 2023, then surged by 2183.33% to $68.5 million in 2024, then rose by 9.49% to $75.0 million in 2025, then fell by 6.67% to $70.0 million in 2026.
  • Business Quant data shows EYPT's Change in Acquisitions & Divestments at $70.0 million in Q1 2026, $75.0 million in Q4 2025, and $66.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 EyePoint 1.06 Mn -221.48 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 70.00 Mn
Mar 31, 2026 70.00 Mn
Dec 31, 2025 75.00 Mn
Dec 31, 2025 75.00 Mn
Sep 30, 2025 66.00 Mn
Sep 30, 2025 66.00 Mn
Jun 30, 2025 103.50 Mn
Jun 30, 2025 103.50 Mn
Mar 31, 2025 79.23 Mn
Mar 31, 2025 79.23 Mn
Dec 31, 2024 68.50 Mn
Dec 31, 2024 68.50 Mn
Sep 30, 2024 67.00 Mn
Sep 30, 2024 67.00 Mn
Jun 30, 2024 25.50 Mn
Jun 30, 2024 25.50 Mn
Mar 31, 2024 22.00 Mn
Mar 31, 2024 22.00 Mn
Dec 31, 2023 3.00 Mn
Dec 31, 2023 3.00 Mn